title: Intracranial dialysis and microinfusion studies suggest that morphine may act in the ventromedial hypothalamus to inhibit female rat sexual behavior.
abstract: The present investigation examined the neural sites and mechanisms of opiate inhibition of female sexual behavior. Systemic administration of morphine (10 mg/kg) significantly reduced ovarian steroid-induced estrous behavior in female rats. This behavioral inhibition was prevented when the opiate receptor antagonist naloxone (5 mg/kg) was administered 30 min prior to morphine. Bilateral infusion of morphine directly into the ventromedial hypothalamus (VMH) also inhibited hormone-dependent estrous behavior for at least 2 hr. Furthermore, naloxone infusion into the VMH 20 min before behavior testing reduced the inhibitory effects of systemically administered morphine on lordosis. These results suggest that morphine may inhibit female sexual behavior by acting directly on the VMH, the primary site at which ovarian steroids facilitate this behavior. In a separate experiment we used in vivo brain microdialysis to test the hypothesis that morphine inhibits lordosis by interfering with norepinephrine (NE) neurotransmission in the VMH. In control rats, the onset of mating was associated with increased NE release in the VMH. Morphine-treated animals displayed neither behavioral estrus nor elevated NE release from the VMH when tested with stimulus males. These data are consistent with the hypothesis that morphine suppresses NE release in the VMH. Nevertheless, mechanisms other than or in addition to attenuation of hypothalamic NE release may contribute to the inhibitory effects of morphine on lordosis.
authors.affiliation: Department of Psychiatry, Albert Einstein College of Medicine, Bronx, New York 10461.
authors.forename: I
authors.initials: I
authors.lastname: Vathy
authors.forename: J
authors.initials: J
authors.lastname: van der Plas
authors.forename: P A
authors.initials: PA
authors.lastname: Vincent
authors.forename: A M
authors.initials: AM
authors.lastname: Etgen
mesh_terms: D000818:Animals; D001931:Brain Mapping; D003956:Dialysis; D004958:Estradiol / Q000502:physiology; D005260:Female; D008845:Microinjections; D009020:Morphine / Q000494:pharmacology*; D009433:Neural Inhibition / Q000187:drug effects* / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology; D011374:Progesterone / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid / Q000187:drug effects* / Q000502:physiology; D012726:Sexual Behavior, Animal / Q000187:drug effects* / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D014697:Ventromedial Hypothalamic Nucleus / Q000187:drug effects* / Q000502:physiology
chemical_list: D011957:Receptors, Opioid; D011374:Progesterone; D004958:Estradiol; D009020:Morphine; D009638:Norepinephrine